CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Daehan New Pharm Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Daehan New Pharm Co., Ltd.
66, Jeyakgongdan 1-gil, Hyangnam-eup
Phone: +82 313536141p:+82 313536141 HWASEONG, 18622  South Korea Ticker: 054670054670
Business Summary
Daehan New Pharm Co., Ltd. is a Korea-based company specialized in the provision of pharmaceutical products. The Company provides two categories of products: human pharmaceutical products and animal pharmaceutical products. Its human pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics, immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics and others. Its animal pharmaceutical products include antibacterial, coccidiostats, antihelmintics, probiotic, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics and others for poultries, cattle, sheep, swine and fishes.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Won SeokLee 46 1/2/2023 1/2/2023
Vice President, Director Yeong JunSong 61 1/1/2011 1/1/2011
Internal Auditor Ju HaLee 51 3/27/2009 3/27/2009
4 additional Officers and Directors records available in full report.

Business Names
Business Name
054670
Daehan New Pharm Co., Ltd.
Daehan New Pharm. Co., Ltd.

General Information
Number of Employees: 377 (As of 12/31/2023)
Outstanding Shares: 14,035,289 (As of 12/31/2023)
Shareholders: 14,069
Stock Exchange: KDQ
Fax Number: +82 313536146


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024